Showing 1 - 10 of 249
discovery of drugs for neglected diseases of the developing world. Although the innovation system has the capability to develop …
Persistent link: https://www.econbiz.de/10005699264
This paper looks at the effects of WTO/TRIPS and pharmaceuticals on women. The focus is on the poor and women. The … benefits of health and modern pharmaceuticals. Access to generic low-priced medicines – including medicines for HIV AIDS …
Persistent link: https://www.econbiz.de/10005699276
A note on the long-awaited Draft National Pharmaceutical Policy 2006. The Policy appears to have taken into consideration consumer needs, paying respect to rational therapeutics. A closer examination of the details---which is what policy critique should do—shows a patchy effort that may...
Persistent link: https://www.econbiz.de/10005696014
The focus of this paper is India. In line with TRIPS India has introduced a product patent regime in pharmaceuticals … from 1 January, 2005. WIll this lead increase in resources deveoted to R and D by Indian companies for the development of … for developing new drugs for neglected diseases? Can India contribte to lowering the cost of new drug development and make …
Persistent link: https://www.econbiz.de/10004988399
development. A search in MEDLINE, EMBASE, Web of Science, and ERIC from the earliest available dates through May 2010, as well as …
Persistent link: https://www.econbiz.de/10009323690
In economic literature, market failure is said to occur when inter alia under the following conditions. 1) When adequate competition does not exist. 2) Buyers and sellers are not well informed. Without information uneducated decisions are made. 3) Resources are not free to move from one industry...
Persistent link: https://www.econbiz.de/10005699309
This paper reports findings from the survey of India’s textiles and clothing exporters. The survey method has been used to identify and assess the impact of Non-Tariff Measures (NTMs) and the Cost of Compliance (COC) expenditure by the exporters. A structured questionnaire has been used...
Persistent link: https://www.econbiz.de/10008543107
THE DRUGS AND COSMETICS (AMENDMENT) BILL, 2005 A Bill further to amend the Drugs and Cosmetics Act, 1940. Under examination with the Committee on Health and Family Welfare On adulterated and spurious drugs
Persistent link: https://www.econbiz.de/10005528115
The Task Force recommends that price regulation should be on the basis of ‘Essentiality’ of the drug and it should be applied only to formulations and not to upstream products, such as bulk drugs. No effort should be made to impose a uniform price, and only a ceiling price should be...
Persistent link: https://www.econbiz.de/10005528148
product patents for pharmaceuticals, this paper provides a rigorously-derived estimate of the possible impact of …-bacterials (i.e., antibiotics) in the Indian pharmaceuticals market. These estimates are then used to carry out counterfactual …
Persistent link: https://www.econbiz.de/10005528220